Kimberly Gentile

BHVN

Kimberly Gentile serves as SVP, Clinical Operations at Biohaven Ltd. (BHVN). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

3 trades

$357.4K

Net Position

Net Seller

$357.4K

Companies Traded

BHVN

Active Period

Oct 2022 – Jan 2026

3 total trades

Most Recent

Sell BHVN

Jan 5, 2026 · $19.4K

Kimberly Gentile's Insider Trading at Biohaven Ltd. (BHVN)

Buys

0 · $0.00

Sells

3 · $357.4K

Total Shares Bought

Total Shares Sold

41,404

BHVN Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value
Jan 5, 2026	Sell	1,956	$9.93	$19.4K
Jan 5, 2025	Sell	1,956	$38.64	$75.6K
Oct 3, 2022	Sell	37,492	$7.00	$262.4K

Related Insiders

Matthew Buten

Chief Financial Officer

BHVNSell · Jan 5, 2026

Bruce Car

Chief Scientific Officer

BHVNSell · Jan 5, 2026

George C. Clark

VP, Chief Accounting Officer

BHVNSell · Jan 5, 2026

Vlad Coric

Chief Executive Officer

BHVNSell · Jan 5, 2026

Gregory Bailey

Director

BHVNBuy · Nov 13, 2025

CHILDS JOHN W

Director

BHVNBuy · Nov 13, 2025

Explore More Insider Trading Data

BHVN Insider Trading Activity

View all insider trades at Biohaven Ltd.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity